We are delighted to announce a new milestone in our development: Dislog Group acquires 100% of the capital of Farmalac, a recognized player in the distribution of packaging items and raw materials for the pharmaceutical industry.
This operation is in line with our external growth strategy, and consolidates our position as an integrated industrial player in the life sciences economy, by extending our presence upstream in the pharmaceutical value chain.
Founded in 1997, Farmalac has established itself as a key partner for pharmaceutical laboratories, and has recently extended its activities to laboratory reagents and consumables.
Thanks to this acquisition, the Dislog Group's healthcare division - which already includes entities such as Steripharma, MegaFlex, SomaPharma, Africare and KPH - has strengthened its ability to provide a complete offering ranging from drug production to the supply of medical devices and dermo-cosmetic solutions.
Moncef Belkhayat, President of Dislog Group:
\"This acquisition is part of our drive to strengthen our healthcare division and consolidate our position as a key player in the pharmaceutical sector. Farmalac brings valuable complementary expertise that will enable us to broaden our offering and better meet market needs.\"
Welcome to the entire FARMALAC team in this new collective adventure!<\/p>","protected":false},"excerpt":{"rendered":"
Nous sommes heureux d\u2019annoncer un nouveau cap dans notre d\u00e9veloppement :\u00a0Dislog Group acquiert 100% du capital de Farmalac, acteur reconnu dans la distribution d\u2019articles de conditionnement et de mati\u00e8res premi\u00e8res pour l\u2019industrie pharmaceutique.Cette op\u00e9ration s\u2019inscrit dans notre strat\u00e9gie de croissance externe et vient\u00a0consolider notre position d\u2019acteur industriel int\u00e9gr\u00e9 dans l\u2019\u00e9conomie de la vie, en \u00e9largissant […]<\/p>\n","protected":false},"author":3,"featured_media":1641,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_eb_attr":"","_templately_pack_id":"","_templately_imported_at":"","_templately_source":"","_templately_import_session_id":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-1635","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsroom"],"_links":{"self":[{"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/posts\/1635","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/comments?post=1635"}],"version-history":[{"count":1,"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/posts\/1635\/revisions"}],"predecessor-version":[{"id":1642,"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/posts\/1635\/revisions\/1642"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/media\/1641"}],"wp:attachment":[{"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/media?parent=1635"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/categories?post=1635"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dislogroup.com\/en\/wp-json\/wp\/v2\/tags?post=1635"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}